An update on the improvement of patient eligibility with the use of new generation endografts for the treatment of abdominal aortic aneurysms.
Nikolaos KontopodisNikolaos GalanakisIfigeneia TzartzalouEmmanouil TavlasEfstratios GeorgakarakosIoannins DimopoulosDimitrios TsetisChristos V IoannouPublished in: Expert review of medical devices (2020)
The Ovation iX system presented a significantly better performance and was eligible for use in a greater number of patients in our series of elective AAA repairs, accommodating patient-specific aortic anatomies. Of course, performing EVAR within the endograft's IFU is important to achieve optimal and durable outcomes. The proximal neck length followed by the size of the access vessels are the two more common factors resulting in loss of eligibility. Except for overall eligibility rates, a case by case decision must be made on which is the most suitable device for each patient, based on the specific characteristics of its unique anatomy.
Keyphrases
- abdominal aortic
- end stage renal disease
- case report
- ejection fraction
- newly diagnosed
- chronic kidney disease
- aortic valve
- prognostic factors
- patients undergoing
- type diabetes
- pulmonary artery
- metabolic syndrome
- insulin resistance
- pulmonary hypertension
- pulmonary arterial hypertension
- combination therapy
- smoking cessation